GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international process and laboratory technology provider, published its preliminary results today for the first half of the current fiscal year. Business of both Group divisions showed highly divergent development as in the past two quarters, with the Biotechnology Division reporting significant growth in sales revenue and profit and the Mechatronics Division posting substantial, cyclically-induced declines.
